Genentech takes the health and safety of our patients, customers, and local communities very seriously, and we continue to focus on helping patients get the Genentech medicines they need during these challenging times. To learn more, including options for financial assistance, please visit our COVID-19 response page or contact the Genentech Patient Resource Center at (877) 436-3683.
ACTEMRA® (tocilizumab)
ALECENSA® (alectinib)
Avastin® (bevacizumab)
COTELLIC® (cobimetinib)
ENSPRYNG® (satralizumab-mwge)
Erivedge® (vismodegib)
Esbriet® (pirfenidone)
Evrysdi® (risdiplam)
GAVRETO® (pralsetinib)
GAZYVA® (obinutuzumab)
HEMLIBRA® (emicizumab-kxwh)
Herceptin® (trastuzumab)
Herceptin HYLECTA™ (trastuzumab and hyaluronidase-oysk)
KADCYLA® (ado-trastuzumab emtansine)
LUCENTIS® (ranibizumab injection)
OCREVUS® (ocrelizumab)
PERJETA® (pertuzumab)
PHESGO™ (pertuzumab, trastuzumab, and hyaluronidase-zzxf)
POLIVY® (polatuzumab vedotin-piiq)
Pulmozyme® (dornase alfa) Inhalation Solution
Rituxan® (rituximab) for Rheumatoid Arthritis (RA)
RITUXAN® (rituximab) for Oncology
Rituxan® (rituximab) for Granulomatosis with Polyangiitis (GPA), Microscopic Polyangiitis (MPA) or Pemphigus Vulgaris (PV)
RITUXAN HYCELA® (rituximab/hyaluronidase human)
ROZLYTREK® (entrectinib)
SUSVIMO™ (ranibizumab injection)
TECENTRIQ® (atezolizumab)
VABYSMO™ (faricimab-svoa)
VENCLEXTA® (venetoclax tablets)
XELODA® (capecitabine)
XOLAIR® (omalizumab) for subcutaneous use
ZELBORAF® (vemurafenib)
Oncology
Ophthalmology
Rheumatology
[Alert banner]
Helping Patients After a Genentech Medicine Is Prescribed
Genentech works every day to help patients who have been prescribed our medicines, so they can focus on what matters most.
Helping Patients After a Genentech Medicine Is Prescribed
Genentech works every day to help patients who have been prescribed our medicines, so they can focus on what matters most.
Coverage
Help understanding benefits and coverage, such as benefits investigations and prior authorization resources
Reimbursement
Sample coding information and resources for denials and appeals
Product Distribution
A list of authorized distributors and specialty pharmacies as well as information on our Spoilage Replacement Program
Over the past 25+ years, Genentech has helped over 2.8 million patients access their Genentech medicines.
In 2021, Genentech Access Solutions helped more than 255,000 eligible patients with access issues.
For assistance, call (877) GENENTECH/(877) 436-3683
6 a.m.–5 p.m. PT, Monday through Friday
Patient Assistance Tool
Find the right assistance option for your patients